Original Research
Published on 23 Oct 2024
Triggered ferroptotic albumin-tocopherol nanocarriers for treating drug-resistant breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1464909
- 1,186 views
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,331 articles
Case Report
Published on 21 Oct 2024
Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1434492
- 1,458 views
Original Research
Published on 17 Oct 2024
A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1337265
- 976 views
Original Research
Published on 16 Oct 2024
HER2-low non-metastatic breast cancer in Qatar—a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1398100
- 1,183 views
- 1 citation
Editorial
Published on 16 Oct 2024
Editorial: Reviews in breast cancer: 2023
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1488263
- 774 views
Systematic Review
Published on 14 Oct 2024
Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1423924
- 1,749 views
- 1 citation
Review
Published on 10 Oct 2024
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1431418
- 3,281 views
- 4 citations
Original Research
Published on 10 Oct 2024
Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1466658
- 1,763 views
- 1 citation
Original Research
Published on 09 Oct 2024
Breast and axillary marking in the neoadjuvant setting: survey results from experts of the Brazilian society of mastology
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1393417
- 1,162 views
Systematic Review
Published on 08 Oct 2024
The impact of internet-based cognitive behavioral therapy on mental health outcomes and life in breast cancer patients: a systematic review and meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1434581
- 1,923 views
Original Research
Published on 04 Oct 2024
The value of chromosome instability detected by low−pass whole−genome sequencing in preoperative prediction of sentinel lymph node metastasis in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1434526
- 924 views
Original Research
Published on 03 Oct 2024
Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer institute
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1424630
- 1,458 views
Original Research
Published on 03 Oct 2024
Efficacy and safety of anlotinib for triple-negative breast cancer with brain metastases
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1439984
- 908 views
Systematic Review
Published on 03 Oct 2024
Effects of mindfulness-based stress reduction on cancer-related fatigue in patients with breast cancer: a meta-analysis of randomized controlled trials
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1425563
- 1,982 views
- 2 citations
Original Research
Published on 01 Oct 2024
Vitamin D receptor is associated with prognostic characteristics of breast cancer after neoadjuvant chemotherapy—an observational study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1458124
- 972 views
Review
Published on 01 Oct 2024
Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1450325
- 2,231 views
- 2 citations